"Ovarian Neoplasms*"[MeSH Major Topic] - Search Results

Year	Number of Results
1945	28
1946	83
1947	90
1948	110
1949	109
1950	111
1951	197
1952	203
1953	219
1954	218
1955	239
1956	198
1957	241
1958	226
1959	213
1960	247
1961	294
1962	292
1963	439
1964	558
1965	332
1966	288
1967	296
1968	283
1969	305
1970	266
1971	313
1972	298
1973	253
1974	267
1975	298
1976	318
1977	347
1978	368
1979	461
1980	389
1981	505
1982	554
1983	592
1984	677
1985	754
1986	702
1987	772
1988	818
1989	990
1990	998
1991	886
1992	1054
1993	1184
1994	1151
1995	1109
1996	1164
1997	1219
1998	1207
1999	1266
2000	1364
2001	1396
2002	1423
2003	1652
2004	1731
2005	1886
2006	2083
2007	2154
2008	2190
2009	2366
2010	2420
2011	2675
2012	2856
2013	2887
2014	3152
2015	3261
2016	3292
2017	3049
2018	3036
2019	3368
2020	3674
2021	3619
2022	3618
2023	3484
2024	1032

1

Trillsch F, Reichenbach J, Czogalla B, Kraus F, Burges A, Mahner S, Kessler M. Trillsch F, et al. J Vis Exp. 2024 Feb 23;(204). doi: 10.3791/66467. J Vis Exp. 2024. PMID: 38465946

2

ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease.

Ledermann JA, Matias-Guiu X, Amant F, Concin N, Davidson B, Fotopoulou C, González-Martin A, Gourley C, Leary A, Lorusso D, Banerjee S, Chiva L, Cibula D, Colombo N, Croce S, Eriksson AG, Falandry C, Fischerova D, Harter P, Joly F, Lazaro C, Lok C, Mahner S, Marmé F, Marth C, McCluggage WG, McNeish IA, Morice P, Nicum S, Oaknin A, Pérez-Fidalgo JA, Pignata S, Ramirez PT, Ray-Coquard I, Romero I, Scambia G, Sehouli J, Shapira-Frommer R, Sundar S, Tan DSP, Taskiran C, van Driel WJ, Vergote I, Planchamp F, Sessa C, Fagotti A. Ledermann JA, et al. Ann Oncol. 2024 Mar;35(3):248-266. doi: 10.1016/j.annonc.2023.11.015. Epub 2024 Feb 1. Ann Oncol. 2024. PMID: 38307807

3

Thermoresponsive carboplatin-releasing prodrugs.

McAdam AD, Batchelor LK, Romano-deGea J, Vasilyev D, Dyson PJ. McAdam AD, et al. J Inorg Biochem. 2024 May;254:112505. doi: 10.1016/j.jinorgbio.2024.112505. Epub 2024 Feb 15. J Inorg Biochem. 2024. PMID: 38377623 Free article.

4

Novel Therapeutics in Ovarian Cancer: Expanding the Toolbox.

Moufarrij S, O'Cearbhaill RE. Moufarrij S, et al. Curr Oncol. 2023 Dec 23;31(1):97-114. doi: 10.3390/curroncol31010007. Curr Oncol. 2023. PMID: 38248092 Free PMC article. Review.

5

Enhancing Immunotherapy in Ovarian Cancer: The Emerging Role of Metformin and Statins.

Almeida-Nunes DL, Silvestre R, Dinis-Oliveira RJ, Ricardo S. Almeida-Nunes DL, et al. Int J Mol Sci. 2023 Dec 25;25(1):323. doi: 10.3390/ijms25010323. Int J Mol Sci. 2023. PMID: 38203494 Free PMC article. Review.

6

Immunotherapy for Ovarian Cancer: Disappointing or Promising?

Deng M, Tang F, Chang X, Liu P, Ji X, Hao M, Wang Y, Yang R, Ma Q, Zhang Y, Miao J. Deng M, et al. Mol Pharm. 2024 Feb 5;21(2):454-466. doi: 10.1021/acs.molpharmaceut.3c00986. Epub 2024 Jan 17. Mol Pharm. 2024. PMID: 38232985 Review.

7

Compelling Story of Ovarian Cancer Screening.

Pavlik EJ, van Nagell JR Jr, Dietrich CS 3rd, Ueland FR. Pavlik EJ, et al. J Clin Oncol. 2024 Apr 1;42(10):1091-1094. doi: 10.1200/JCO.23.02424. Epub 2024 Feb 2. J Clin Oncol. 2024. PMID: 38306587 No abstract available.

8

Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway.

Licaj M, Mhaidly R, Kieffer Y, Croizer H, Bonneau C, Meng A, Djerroudi L, Mujangi-Ebeka K, Hocine HR, Bourachot B, Magagna I, Leclere R, Guyonnet L, Bohec M, Guérin C, Baulande S, Kamal M, Le Tourneau C, Lecuru F, Becette V, Rouzier R, Vincent-Salomon A, Gentric G, Mechta-Grigoriou F. Licaj M, et al. Nat Commun. 2024 Feb 12;15(1):1312. doi: 10.1038/s41467-024-45595-3. Nat Commun. 2024. PMID: 38346978 Free PMC article.

9

Mirvetuximab soravtansine: an oasis in the desert?

Bonilla L, Kasherman L, Manso L, Madariaga A. Bonilla L, et al. Int J Gynecol Cancer. 2024 Apr 1;34(4):478-479. doi: 10.1136/ijgc-2024-005400. Int J Gynecol Cancer. 2024. PMID: 38388176 No abstract available.

10

EZH2-mediated development of therapeutic resistance in cancer.

Kaur P, Shankar E, Gupta S. Kaur P, et al. Cancer Lett. 2024 Apr 1;586:216706. doi: 10.1016/j.canlet.2024.216706. Epub 2024 Feb 7. Cancer Lett. 2024. PMID: 38331087 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

83,822 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

83,822 results

Results by year